What is Artiva Biotherapeutics, Inc.'s total revenue?

Artiva Biotherapeutics, Inc. (ARTV) reported total revenue of $0 in Q4 2025.

What does total revenue mean?

The aggregate of all revenue from the company's operations — the top line from which all profitability metrics are derived.

Artiva Biotherapeutics, Inc. ARTV Total Revenue

Discontinued — last reported Q4 '25

Total Revenue at other companies

Bristol-Myers SquibbBMY

$11.49B+2.6%

Gilead SciencesGILD

$6.96B+4.4%

ImmunityBio, Inc.IBRX

$44.21M+168%

Nektar TherapeuticsNKTR

$10.86M+3.8%

Iovance Biotherapeutics, Inc.IOVA

$71.43M+44.8%

AnaptysBio, Inc.ANAB

$25.56M-8.0%

Other financials

Income statement

See full

Operating income-$24.4M-10.2%

Net income-$23.5M-15.8%

EPS (diluted)-$0.95-14.5%

Balance sheet

See full

Cash & equivalents$21.4M-30.6%

Total debt$10.3M-26.7%

Total equity$87.8M-48.0%

Total assets$106.0M-44.6%

Cash flow

See full

Operating cash flow-$21.0M-5.6%

CapEx$242.0K-52.6%

Free cash flow-$21.2M-4.1%

Valuation

See full

Market cap$429.03M+1,015%

Enterprise value$417.88M+1,832%

Profitability

See full

Operating margin-83.9%—

Net margin-79.3%—

Returns & leverage

See full

Return on equity-67.9%—

Debt / equity0.1×0.0×

Current ratio8.2×-5.8×

Where this comes from

Reported directly by Artiva Biotherapeutics, Inc. in its filing.

Tagged under the XBRL concept us-gaap:Revenues.

The official record: Artiva Biotherapeutics, Inc.’s 10-K, filed March 10, 2026, on SEC EDGAR. View the filing →

Ask your AI about Artiva Biotherapeutics, Inc.'s total revenue.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Artiva Biotherapeutics, Inc.'s total revenue?: Artiva Biotherapeutics, Inc. (ARTV) reported total revenue of $0 in Q4 2025.
What does total revenue mean?: The aggregate of all revenue from the company's operations — the top line from which all profitability metrics are derived.